Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 3
1978 1
1979 7
1980 24
1981 35
1982 35
1983 98
1984 94
1985 126
1986 123
1987 142
1988 117
1989 150
1990 124
1991 111
1992 124
1993 135
1994 116
1995 108
1996 109
1997 99
1998 107
1999 103
2000 77
2001 78
2002 112
2003 108
2004 109
2005 105
2006 82
2007 115
2008 97
2009 100
2010 100
2011 106
2012 112
2013 103
2014 120
2015 119
2016 113
2017 94
2018 99
2019 102
2020 91
2021 86
2022 74
2023 60
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

4,232 results

Results by year

Filters applied: . Clear all
Page 1
Piroxicam.
Mostafa GAE, Al-Dosseri AS, Al-Badr AA. Mostafa GAE, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:199-474. doi: 10.1016/bs.podrm.2019.10.007. Epub 2019 Dec 18. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164968
A comprehensive profile of piroxicam including the nomenclatures, formulae, elemental composition, appearance, uses and applications. ...
A comprehensive profile of piroxicam including the nomenclatures, formulae, elemental composition, appearance, uses and applications. …
Piroxicam: Source for Synthesis of Central Nervous System (CNS) Acting Drugs.
Saganuwan SA. Saganuwan SA. Cent Nerv Syst Agents Med Chem. 2017;17(2):135-140. doi: 10.2174/1871524916666160719102335. Cent Nerv Syst Agents Med Chem. 2017. PMID: 27439371 Review.
Whereas the nitrogen group may be responsible for cholinergic effect in gaglia and striated muscle. Because of the carboxylic functional group (COOH), piroxicam may display depressant effect. Hence C = O, C = N and C = C in piroxicam may change due to biofield treat …
Whereas the nitrogen group may be responsible for cholinergic effect in gaglia and striated muscle. Because of the carboxylic functional gro …
In vivo Piroxicam Metabolites: Possible Source for Synthesis of Central Nervous System (CNS) Acting Depressants.
Saganuwan SA. Saganuwan SA. Cent Nerv Syst Agents Med Chem. 2017;17(3):172-177. doi: 10.2174/1871524917666161111093759. Cent Nerv Syst Agents Med Chem. 2017. PMID: 27834137 Review.
BACKGROUND: Piroxicam has been reported to be convertible to Central Nervous System (CNS) acting agents. ...RESULTS: Piroxicam is convertible to hydroxymethylated metabolite which may be converted to barbiturates such as thiopentone and thiamylal. ...
BACKGROUND: Piroxicam has been reported to be convertible to Central Nervous System (CNS) acting agents. ...RESULTS: Piroxicam
Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
Olkkola KT, Brunetto AV, Mattila MJ. Olkkola KT, et al. Clin Pharmacokinet. 1994 Feb;26(2):107-20. doi: 10.2165/00003088-199426020-00004. Clin Pharmacokinet. 1994. PMID: 8162655 Review.
Age of the patient and renal or hepatic dysfunction do not seem to have any major effect on the pharmacokinetics of piroxicam. The drug reduces the renal excretion of lithium to a clinically significant extent, but the clinical significance of piroxicam-aspirin (ace …
Age of the patient and renal or hepatic dysfunction do not seem to have any major effect on the pharmacokinetics of piroxicam. The dr …
Piroxicam-induced photosensitive dermatitis.
McKerrow KJ, Greig DE. McKerrow KJ, et al. J Am Acad Dermatol. 1986 Dec;15(6):1237-41. doi: 10.1016/s0190-9622(86)70296-x. J Am Acad Dermatol. 1986. PMID: 2948973
Eleven patients had piroxicam-induced photosensitivity when first seen. Six were photopatch-tested to piroxicam (2%, 5%, 20% concentrations); all tests were positive. ...
Eleven patients had piroxicam-induced photosensitivity when first seen. Six were photopatch-tested to piroxicam (2%, 5%, 20% c …
Piroxicam-induced agranulocytosis.
García S, Belda J, Linares M, Miguel-Garcia A, Miguel-Sosa A, Navarro M, Miguel-Borja JM. García S, et al. Drug Intell Clin Pharm. 1988 Dec;22(12):1003. doi: 10.1177/106002808802201216. Drug Intell Clin Pharm. 1988. PMID: 3243167 No abstract available.
Piroxicam: what's new?
Huskisson EC. Huskisson EC. Eur J Rheumatol Inflamm. 1981;4(3):275-6. Eur J Rheumatol Inflamm. 1981. PMID: 6242946 No abstract available.
Piroxicam: new dosage forms.
Norris E, Guttadauria M. Norris E, et al. Eur J Rheumatol Inflamm. 1987;8(1):94-104. Eur J Rheumatol Inflamm. 1987. PMID: 3305038 Clinical Trial.
(Ed.: The parenteral and topical formulations were launched after the symposium was held, and are now available). The piroxicam suppository offers an alternative to the oral route of administration. ...Piroxicam topical gel (0.5%) has been demonstrated to have anti- …
(Ed.: The parenteral and topical formulations were launched after the symposium was held, and are now available). The piroxicam suppo …
Clinical pharmacokinetics of tenoxicam.
Nilsen OG. Nilsen OG. Clin Pharmacokinet. 1994 Jan;26(1):16-43. doi: 10.2165/00003088-199426010-00003. Clin Pharmacokinet. 1994. PMID: 8137596 Review.
Efficacy and tolerability of tenoxicam--an overview.
Vischer TL. Vischer TL. Eur J Rheumatol Inflamm. 1987;9(2):51-7. Eur J Rheumatol Inflamm. 1987. PMID: 3329109 Review.
Most trials comparing tenoxicam with another NSAID have used piroxicam, an earlier oxicam derivative which also has a long half-life. ...In short-term studies 11% of patients receiving 20 mg tenoxicam and 18% on 40 mg tenoxicam experienced side-effects (p less than 0.01), …
Most trials comparing tenoxicam with another NSAID have used piroxicam, an earlier oxicam derivative which also has a long half-life. …
4,232 results